rs200353362

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004204.5(PIGQ):​c.620G>A​(p.Arg207Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000347 in 1,601,774 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00066 ( 3 hom., cov: 34)
Exomes 𝑓: 0.00031 ( 6 hom. )

Consequence

PIGQ
NM_004204.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.592

Publications

4 publications found
Variant links:
Genes affected
PIGQ (HGNC:14135): (phosphatidylinositol glycan anchor biosynthesis class Q) This gene is involved in the first step in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes a N-acetylglucosaminyl transferase component that is part of the complex that catalyzes transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
PIGQ Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 77
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0045292675).
BP6
Variant 16-574694-G-A is Benign according to our data. Variant chr16-574694-G-A is described in ClinVar as Benign. ClinVar VariationId is 456051.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000663 (101/152328) while in subpopulation EAS AF = 0.0145 (75/5178). AF 95% confidence interval is 0.0118. There are 3 homozygotes in GnomAd4. There are 59 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGQNM_004204.5 linkc.620G>A p.Arg207Gln missense_variant Exon 2 of 11 ENST00000321878.10 NP_004195.2 Q9BRB3-2B2RAU6
PIGQNM_148920.4 linkc.620G>A p.Arg207Gln missense_variant Exon 2 of 10 NP_683721.1 Q9BRB3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGQENST00000321878.10 linkc.620G>A p.Arg207Gln missense_variant Exon 2 of 11 1 NM_004204.5 ENSP00000326674.6 Q9BRB3-2

Frequencies

GnomAD3 genomes
AF:
0.000657
AC:
100
AN:
152210
Hom.:
3
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0145
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00113
AC:
262
AN:
230994
AF XY:
0.00101
show subpopulations
Gnomad AFR exome
AF:
0.0000706
Gnomad AMR exome
AF:
0.0000295
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0137
Gnomad FIN exome
AF:
0.0000645
Gnomad NFE exome
AF:
0.0000383
Gnomad OTH exome
AF:
0.00104
GnomAD4 exome
AF:
0.000314
AC:
455
AN:
1449446
Hom.:
6
Cov.:
39
AF XY:
0.000309
AC XY:
223
AN XY:
720834
show subpopulations
African (AFR)
AF:
0.0000599
AC:
2
AN:
33362
American (AMR)
AF:
0.0000225
AC:
1
AN:
44510
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26022
East Asian (EAS)
AF:
0.00796
AC:
315
AN:
39556
South Asian (SAS)
AF:
0.000537
AC:
46
AN:
85732
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45392
Middle Eastern (MID)
AF:
0.000206
AC:
1
AN:
4860
European-Non Finnish (NFE)
AF:
0.0000207
AC:
23
AN:
1109980
Other (OTH)
AF:
0.00112
AC:
67
AN:
60032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000663
AC:
101
AN:
152328
Hom.:
3
Cov.:
34
AF XY:
0.000792
AC XY:
59
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.0000240
AC:
1
AN:
41584
American (AMR)
AF:
0.000784
AC:
12
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.0145
AC:
75
AN:
5178
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4828
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68012
Other (OTH)
AF:
0.000947
AC:
2
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000755
Hom.:
1
Bravo
AF:
0.000661
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.00105
AC:
126
Asia WGS
AF:
0.0130
AC:
45
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PIGQ: BP4, BS1, BS2 -

Epilepsy Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
2.3
DANN
Benign
0.24
DEOGEN2
Benign
0.027
.;.;.;T;.
Eigen
Benign
-0.96
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.44
N
LIST_S2
Benign
0.80
.;T;T;T;T
MetaRNN
Benign
0.0045
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.16
N;N;.;N;N
PhyloP100
0.59
PrimateAI
Benign
0.20
T
PROVEAN
Benign
-0.49
N;N;N;N;N
REVEL
Benign
0.038
Sift
Benign
1.0
T;T;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T
Polyphen
0.0050
B;B;.;B;B
Vest4
0.064
MutPred
0.27
Gain of catalytic residue at R207 (P = 0.0127);Gain of catalytic residue at R207 (P = 0.0127);Gain of catalytic residue at R207 (P = 0.0127);Gain of catalytic residue at R207 (P = 0.0127);Gain of catalytic residue at R207 (P = 0.0127);
MVP
0.30
MPC
0.16
ClinPred
0.0037
T
GERP RS
-4.8
Varity_R
0.021
gMVP
0.21
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200353362; hg19: chr16-624694; COSMIC: COSV50313769; COSMIC: COSV50313769; API